|
Volumn 17, Issue 6, 2011, Pages 683-685
|
Incidence of severe adverse events requiring hospital care after trastuzumab infusion for metastatic breast cancer: A nationwide survey using an administrative claim database
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPECITABINE;
DOCETAXEL;
NAVELBINE;
PACLITAXEL;
TRASTUZUMAB;
AGRANULOCYTOSIS;
ANEMIA;
ANXIETY DISORDER;
BREAST CANCER;
BRONCHITIS;
CELLULITIS;
CHEMOTHERAPY INDUCED EMESIS;
COMA;
COMBINATION CHEMOTHERAPY;
CONGESTIVE HEART FAILURE;
CONSTIPATION;
CYSTITIS;
DEPRESSION;
DIARRHEA;
DISEASE SEVERITY;
DIZZINESS;
DRUG EFFICACY;
DYSTHYMIA;
ECZEMA;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HERPES ZOSTER;
HUMAN;
INTERSTITIAL LUNG DISEASE;
LARYNGITIS;
LEG THROMBOPHLEBITIS;
LETTER;
LIVER FUNCTION TEST;
LOADING DRUG DOSE;
METASTASIS;
MONOTHERAPY;
MORBIDITY;
MYCOSIS;
PANCYTOPENIA;
PHARYNGITIS;
PLEURA EFFUSION;
PNEUMONIA;
POLYNEUROPATHY;
QUALITY OF LIFE;
RECTUM ULCER;
RESPIRATORY FAILURE;
SEPSIS;
SIDE EFFECT;
SKIN INFECTION;
SKIN ULCER;
SLEEP DISORDER;
STOMATITIS;
TONSILLITIS;
UNSPECIFIED SIDE EFFECT;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
URTICARIA;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
DATABASES, FACTUAL;
FEMALE;
HUMANS;
INCIDENCE;
MIDDLE AGED;
NEOPLASM METASTASIS;
|
EID: 80755133435
PISSN: 1075122X
EISSN: 15244741
Source Type: Journal
DOI: 10.1111/j.1524-4741.2011.01170.x Document Type: Letter |
Times cited : (7)
|
References (6)
|